Skip to main content

Pooja Mahajan

Label-free Array Systems Market Incredible Potential Examined in New Research Report

7 min read

Transparency Market Research (TMR) has published a new report on the label-free array systems market for the forecast period of 2019–2027. According to the report, the global label-free array systems market was valued at ~ US$ 1.1 Bn in 2018, and is projected to expand at a CAGR of ~ 7% from 2019 to 2027.

Label-Free Array Systems Market: Introduction

Label-free array techniques eliminate the use of heavy florescent and other labels for the detection of new molecules. Label-free array techniques have various advantages over traditional labelled techniques, such as fast delivery, reliability, and robust & accurate results in real time. Label-free array techniques do not use any radioactive or fluorescent labels, tags, dyes, or any specialized reagent for the preparation of assays, which reduces overall cost of the technique.

Labelled detection techniques use labels, dyes, or radioactive and fluorescent labels to detect drug molecules, creating liabilities such as unfavorable and unanticipated reactions of the labels with the molecule of study. This could change the physico-chemical properties of the molecule, leading to false positive results. Label-free techniques do not require labelling, thus keeping the molecule under study free from any interactions. This is a key factor boosting the growth of the global label-free array systems market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17225

Surface Plasmon Resonance to be Highly Attractive

The report offers detailed segmentation of the global label-free array systems market based on technique, application, and end user. In terms of technique, the surface plasmon resonance segment is poised to account for a prominent share of the global label-free array systems market during the forecast period, due to the increase in application of SPR in drug discovery, kinetic analysis, and antigen antibody reaction in protein microarrays. Moreover, various advantages of SPR technology such as real-time monitoring, ability to replicate the results, and ease of assay preparation are boosting the growth of the segment in the label-free array systems market.

Availability of advanced surface plasmon resonance systems such as GE Healthcare’s Biacore instruments is a key factor which leads to the penetration of the surface plasmon resonance technique in the global label-free array systems market. The microcantilever segment is anticipated to expand at a high CAGR during the forecast period in the label-free array systems market. The microcantilever technique can be effectively applied in applications such as monitoring of DNA-binding proteins, detecting the bioterrorism agent anthrax, analysis of biomarkers, and to weigh individual vaccine viruses and bacteria. Microcantilever-based sensors improve the capability to detect biological agents by order of magnitude. High surface-to-volume ratio, lightweight, and the small size of these systems boost the growth of the segment in the label-free array systems market.

Request for Analysis of COVID-19 Impact on Label-Free Array Systems Market -https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=17225

Increase in R&D Investments to Fuel Drug Discovery

In terms of application, the global label-free array systems market has been segregated into drug discovery, biomolecular interactions, detection of disease biomarkers, and others. The drug discovery segment dominated the global label-free array systems market in 2018. Increase in applications of label-free techniques in the drug discovery segment, rise in R&D costs, and surge in the demand for new and targeted drugs in the field of the life science and pharmaceutical sectors drive the drug discovery segment of the global label-free array systems market. Using label-free techniques such as detection and quantification of a wide array of interactions via a local change in refractive index, including those between a drug molecule and its receptor, can be studied. Increased government funding for research and rise in applications of label-free techniques in the drug discovery segment are expected to propel the segment in the label-free array systems market during the forecast period.

Pharmaceutical and Biotechnology Industries Offer Huge Opportunities

Increase in R&D spending by pharmaceutical and biotech companies is one of the factors driving the global label-free array systems market. A large number of companies focus on new and targeted drug development to gain a competitive edge in the highly fragmented industry. Growth of the pharmaceutical and biotechnology industries segment can be attributed to the patent expiry of drugs, which is putting the pharmaceutical industry under intense pressure, with R&D costs continuing to rise, but the number of drug discoveries remaining static. The contract research organizations segment is likely to expand at a significant CAGR from 2019 to 2027. Increase in clinical trial studies augment the contract research organizations segment in the label-free array systems market.

Global Label-free Array Systems Market: Prominent Regions

North America to Create High Incremental Opportunity

In terms of revenue, North America is projected to be a prominent region in the global label-free array systems market from 2019 to 2027. This can be ascribed to the early adoption of technologically-advanced label-free array systems in the U.S. and Canada. The presence of leading market players, their growing investments in research, and FDA approvals for the commercial launch of label-free array systems boost the growth of the label-free array systems market in North America. Europe was a key market for label-free array systems in 2018. Growth of the label-free array systems market in the region can be attributed to the increase in the number of biotechnology companies with focus on research & development. The label-free array systems market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, due to the growing trend among drug manufacturers and academic organizations toward adopting label-free methods earlier in the drug discovery process.

Buy Label-free Array Systems Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=17225<ype=S

Mergers & Acquisitions and Product Development & Launches in International Market: Key Trends among Leading Players

The report provides profiles of the leading players operating in the global label-free array systems market. GE Healthcare, Agilent Technologies, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, GWC Technologies, PerkinElmer, Inc., Attana AB, and BiOptix, Inc. are the major players operating in the label-free array systems market.

These players have adopted strategies such as mergers and acquisitions to expand their label-free array systems product portfolio and new product development & launches to increase market presence. In November 2018, Agilent Technologies, Inc. acquired ACEA Biosciences, Inc. (ACEA), which helped it to expand its label-free array systems portfolio. In April 2017, Pall ForteBio launched the Octet RED96E System in the market for more versatile biologics characterization.

More Trending Reports by Transparency Market Research –

Video Telemedicine Market: https://www.prnewswire.com/news-releases/hipaa-complaint-video-consultations-gain-patient-acceptance-video-telemedicine-market-to-garner-cagr-of-13-during-2020--2030-finds-tmr-301072555.html

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

Plantar Fasciitis Treatment Market Outlook, Trend, Growth and Share Estimation Analysis

6 min read

Transparency Market Research (TMR) has published a new report on the plantar fasciitis treatment market for the forecast period of 2019–2027. According to the report, the global plantar fasciitis treatment market was valued at ~ US$ 695 Mn in 2018, and is projected to expand at a CAGR of 4.3% from 2019 to 2027. Rise in the patient population and surge in the adoption of technologically-advanced products are the major factors anticipated to drive the global plantar fasciitis treatment market from 2019 to 2027.

Increase in Burden of Patient Population to Drive Plantar Fasciitis Treatment Market

·        Plantar fasciitis is one of the most common foot pain conditions. Plantar fasciitis is primarily caused due to repetitive strain on the ankle, leading to progressive wear and tear and degeneration of plantar fascia, a thick connective tissue covering the lower side of the foot.

·        The obese and geriatric populations are more prone to plantar fasciitis. It leads to sharp pain and other complications, in which, plantar fascia, a tissue connecting the heel and the toe bones becomes less flexible and more constrained.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47658

·        Rise in the number of individuals living sedentary lifestyles coupled with changes in eating habits leads to an increase in obesity, which puts pressure on the joints and ankles, and can result in plantar fasciitis.

·        Increase in the percentage of geriatric and obese populations is likely to propel the number of patients suffering from plantar fasciitis.

·        Moreover, prolonged standing, weight bearing, ill-fitted shoes, incorrect walking posture, and sudden rise in sports activities can trigger micro-tears in the plantar fascia, and lead to plantar fasciitis.

·        This multi-factorial etiology of the disease is anticipated to drive the global plantar fasciitis treatment market during the forecast period.

Orthotics Treatment Type to Gain Market Share and offer Lucrative Opportunities

·        The report offers detailed segmentation of the global plantar fasciitis treatment market based on type, end user, and region. In terms of type, the plantar fasciitis treatment market has been segmented into medication therapy (oral and parenteral), orthotics, shockwave therapy (extracorporeal shock wave therapy (ESWT) and intracorporeal pneumatic shockwave therapy (IPST)), surgery, and others. Rise in the awareness about the use of orthotics and proven efficacy of orthotics in managing and correcting plantar fasciitis are the factors driving the orthotics segment in the plantar fasciitis treatment market.

·        Based on end user, the global plantar fasciitis treatment market has been classified into hospitals, clinics, and others. The hospitals segment is expected to be the largest market segment due to an increase in the number of patients suffering from plantar fasciitis, and rise in the number of patients coming in through reimbursement programs such as Medicare.

Request for Analysis of COVID-19 Impact on Plantar Fasciitis Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=47658

Asia Pacific Plantar Fasciitis Treatment Market to Grow at a Rapid Pace

·        North America held a prominent share of the global plantar fasciitis treatment market in terms of revenue in 2018, and is projected to sustain its market share during the forecast period. The prevalence and diagnosis rates of plantar fasciitis is increasing rapidly across the world. Rise in the number of obese people in the U.S. and changes in lifestyle drive the plantar fasciitis treatment market in North America.

·        The plantar fasciitis treatment market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. Increase in the penetration of leading players in the region is expected to boost the plantar fasciitis treatment market in the region during the forecast period.

·        The plantar fasciitis treatment market in Asia Pacific is primarily driven by the surge in investments in healthcare infrastructure, rise in disposable income of people, economic growth, large population base with chronic diseases & other foot pain conditions, and expansion in the distribution networks of leading players in the region to establish themselves in lucrative plantar fasciitis treatment

Buy Plantar Fasciitis Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=47658<ype=S

Dr. Scholl's, Superfeet Worldwide, Inc., Hanger, Inc., and Pfizer to Lead Market

The report contains the profiles of leading players operating in the global plantar fasciitis treatment market. These include Hanger, Inc., Bayer Group (Dr. Scholl's), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.

·        Hanger, Inc. is a U.S.-based manufacturer and distributor of orthotic and prosthetic devices, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. It offers integrated rehabilitative solutions with innovative technologies and efficient & effective clinical solutions.

·        Bayer is a life sciences company operating in the pharmaceutical, consumer health, animal health, and agriculture domains, with over 150 years of history and core competences in the areas of healthcare and agriculture. The company’s foot care products are covered under the consumer health segment, which also includes products in dermatology, nutritional supplements, analgesic, digestive health, cold, allergy, sinus and flu, and sun care.

·        Pfizer, Inc. is a global biopharmaceutical company that operates through five segments: specialty care & oncology, primary care, established products, emerging markets, and animal & consumer healthcare. The consumer health products segment includes Advil, Centrum, and Robitussin. The emerging markets segment offers non-pharmaceutical products in various therapeutic categories such as pain management, dietary supplements, personal care, and respiration.

More Trending Reports by Transparency Market Research –

Arterial Stents Market: https://www.biospace.com/article/arterial-stents-market-introduction-of-new-product-variants-makes-coronary-stents-dominant/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

HIV/AIDS Immunoassay Diagnostics Market Overview and Regional Outlook Study

9 min read

Transparency Market Research (TMR) has published a new report titled, ‘HIV/AIDS Immunoassay Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the report, the global HIV/AIDS immunoassay diagnostics market was valued at ~US$ 550 Mn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.

Overview

·        Human immunodeficiency virus (HIV) belongs to the retrovirus family. HIV is transmitted through unprotected sex with an infected person, transfusion of HIV infected blood, and sharing needles contaminated with HIV infected blood.

·        Rise in prevalence of HIV across the globe, HIV infections among young population, blood donations, awareness about HIV diagnosis across the globe, and favorable initiatives by governments for HIV/AIDS diagnosis and prevention are key factors that are anticipated to drive the global HIV/AIDS immunoassay diagnostics market during the forecast period

·        North America held a major share of the global HIV/AIDS immunoassay diagnostics market in 2018. It is primarily driven by factors such as presence of key market players, highly structured health care industry, and key developments by market players such as product launch approvals, key mergers, and acquisitions.

·        The HIV/AIDS immunoassay diagnostics market in Asia Pacific is expected to expand at a high CAGR of ~7% from 2019 to 2027. Increase in the number of people with sexually transmitted diseases, rise in incidence of HIV infection among young adults, product approvals, and rise in awareness about HIV/AIDS diseases are factors anticipated to fuel the growth of the HIV/AIDS immunoassay diagnostics market in the region.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74619

Increase in Prevalence of HIV Infections across the Globe to Drive Market

·        HIV is basically transmitted through unprotected sex with an infected person, transfusion of HIV infected blood, and sharing needles contaminated with HIV infected blood. Rise in the number of patients with HIV contamination at an alarming rate in several countries is a major factor likely to drive the revenue of a large number of diagnostic labs and clinics in the near future.

·        According to the WHO, HIV continues to be a major global public health issue. Based on UNAIDS report 2018, 39.6 million adults and children were living with HIV and approximately 940,000 individuals died from HIV globally.

·        Approximately 1.7 million people were newly infected with HIV globally, in 2018

·        Majority of the affected population lives in lower and middle-income countries. Middle East & Africa and Asia Pacific have high incidence rate of HIV infections across the globe.

·        Hence, rise in prevalence of HIV is projected to increase the demand for HIV diagnostics which, in turn, is anticipated to boost the growth of the market

·        According to HIV.org, approximately 1.1 million people in the U.S. were living with HIV in 2018

·        According to Avert.org, approximately 2.2 million people in Western Europe were living with HIV infections in 2018. Moreover, Eastern Europe witnessed a 29% increase in new HIV infections annually between 2010 and 2018.

Request for Analysis of COVID-19 Impact on HIV/AIDS Immunoassay Diagnostics Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74619

Kits & Reagents Dominated HIV/AIDS Immunoassay Diagnostics Market

·        In terms of product, the global HIV/AIDS immunoassay diagnostics market can be classified into analyzers and kits & reagents

·        The kits & reagents segment dominated the global HIV/AIDS immunoassay diagnostics market in 2018 and the trend is projected to continue during the forecast period. Several key market players are investing in the expansion of their assay offerings. Leading market players offer more than 100 tests across different application areas using the CLIA technology. Moreover, low cost and short test time are likely to propel the segment during the forecast period.

CLIA Technology to Lead Global HIV/AIDS Immunoassay Diagnostics Market

·        In terms of technology, the global HIV/AIDS immunoassay diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and others (immunofluorescent assay (IFA), radioimmunoassay (RIA), and enzyme-linked fluorescent assay (ELFA)). The chemiluminescence immunoassay (CLIA) segment accounted for majority of the market share in 2018. The segment is projected to register the highest market attractiveness index by 2027. High sensitivity of the CLIA technology and its ability to detect HIV-1 and HIV-2 antibodies and p24 antigen separately, which is useful in the early diagnosis of HIV infections, is anticipated to drive the segment. Moreover, availability of a wide range of assays and high throughput of CLIA analyzers are likely to propel the segment from 2019 to 2027.

·        The ELISA segment is anticipated to expand at a rapid CAGR during the forecast period. ELISA is considered as the gold standard technique and a screening tool for HIV infections.

Diagnostic Laboratories to Flourish in Global HIV/AIDS Immunoassay Diagnostics Market

·        In terms of end user, the global HIV/AIDS immunoassay diagnostics market has been categorized into hospitals, diagnostic laboratories, blood banks, and others

·        The diagnostic laboratories segment held a major share of the global HIV/AIDS immunoassay diagnostics market in 2018. Growth of the segment can be attributed to the increase in incidence rate of HIV infections leading to high demand for early disease diagnosis. Moreover, high-volume consumption of immunoassay reagents and test kits such as ELISA and CLIA in diagnostic laboratories for the diagnosis of HIV infections is expected to boost the growth of the segment.

Buy HIV/AIDS Immunoassay Diagnostics Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=74619<ype=S

North America to Dominate Global Market; Asia Pacific to Offer Significant Incremental Opportunity

·        In terms of region, the global HIV/AIDS immunoassay diagnostics market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America held a major share of the global HIV/AIDS immunoassay diagnostics market in 2018. It is primarily driven by factors such as presence of key market players, highly structured health care industry, and key development by market players such as product launch approvals, key mergers, and acquisitions.

·        In May 2016, DiaSorin and Beckman Coulter signed an agreement for the promotion and distribution of DiaSorin’s hepatitis (A, B, and C) and HIV tests on DiaSorin’s Liaison XL platform in the U.S.

·        In October 2017, Siemens Healthineers launched its new, integrated, automated immunoassay and chemistry analyzer ‘Atellica’. This move is estimated to attract more consumers toward complete laboratory automation and integration. Moreover, high awareness of HIV/AIDS disease among people is leading to the adoption of new therapy for diagnosis of HIV/AIDS. This factor is anticipated to drive the HIV/AIDS immunoassay diagnostics market in the region

·        The HIV/AIDS immunoassay diagnostics market in Asia Pacific is projected to grow at a rapid pace in the near future. India, China, and Australia are expected to be lucrative markets, owing to setting up of new diagnostic laboratories and rise in awareness about the benefits of diagnosis of HIV using kits, reagents, and assays. For instance, in June 2017, Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE) received approval from the U.S. FDA for its automated immunoassay analyzer ‘Maglumi 2000’, becoming the first China-based manufacturer to receive this approval. This product approval is expected to enable the company to enhance its product portfolio and strengthen its market position in China.

Growth Strategies of Key Players

·        Key players operating in the global HIV/AIDS immunoassay diagnostics market are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Siemens Healthineers AG, DiaSorin S.p.A., Abbott Laboratories, Ortho Clinical Diagnostics (a part of Carlyle Group), Shenzhen New Industries Biomedical Engineering Co., Ltd., bioMérieux SA, and Fujirebio (Miraca Group)

·        These companies engage in research & development activities to develop novel products in order to expand product offerings and customer base. For instance, in June 2017, Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE) received approval from the U.S. FDA for its automated immunoassay analyzer ‘Maglumi 2000’, becoming the first China-based manufacturer to receive this approval. In June 2016, Ortho Clinical Diagnostics received the CE Mark approval for its Vitros HIV combo test, which can be used in its VITROS series of automated immunoassay analyzers. This has expanded the company’s portfolio in infectious disease assays.

More Trending Reports by Transparency Market Research –

Interventional Radiology Drainage Procedures Market:

https://www.biospace.com/article/interventional-radiology-drainage-procedures-market-catheters-to-dominate-global-market/

Read our Case study at

https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

C-arms Market Research Described in a New Market Report

5 min read

C-arms Market: Introduction

Transparency Market Research (TMR) has published a new report titled, ‘C-arms Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the report, the global C-arms market was valued at ~US$ 1.8 Bn in 2018 and is projected to expand at a CAGR of ~3% from 2019 to 2027. High prevalence and increase in incidence of acute and chronic disorders and surge in global geriatric population are the major factors anticipated to drive the global C-arms market from 2019 to 2027.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74778

Technological Developments to Drive Global Market

The global X-ray market is responding positively to the new and improved C-arm systems or machines, with increase in uptake of technologically advanced C-arms. Additionally, digital C-arm systems are comparatively newer than analog C-arm systems, and have been able to make inroads into the C-arms market to become a market leader. Recent introduction of advanced, highly portable digital C-arms has resulted in an increased demand for C-arms in the global market. Recently commercialized products such as mobile and 3D C-arms fulfill these requirements, hence, demand and acceptance of these systems have surged across the world.

Most of the developed countries have high geriatric population. Around 82% of the people who succumb to a coronary artery disease are aged 65 years and above. According to WHO estimates, the geriatric population is expected to increase at the fastest rate in developed countries such as the U.S., the U.K., and Japan. Favorable healthcare policies and advancements in health care facilities in countries such as the U.S., Japan, the U.K., and countries in Western Europe have improved access to various diagnostic and treatment services. This, in turn, has increased life expectancy of the population. Increase in the geriatric population is anticipated to boost the growth of the global C-arms market during the forecast period.

Request for Analysis of COVID-19 Impact on C-arms Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74778

Mobile C-arms to Offer Lucrative Opportunities

The report offers detailed segmentation of the global C-arms market based on product, technology, detector, application, end user, and region. In terms of product, the global market has been bifurcated into fixed C-arms and mobile C-arms. The mobile C-arms segment has been sub-segmented into full-size mobile C-arms, and mini C-arms. Based on technology, the global C-arms market has been classified into 2D imaging technology and 3D imaging technology. In terms of detector, the global market has been categorized into image intensifier and flat panel detector.

Based on application, the global C-arms market has been divided into ortho/trauma/spine surgeries, vascular surgeries, cardiac surgeries, urologic procedures, gastroenterology, and other surgeries. In terms of end user, the global C-arms market has been classified into hospitals & clinics, ambulatory surgical centers, and others. Hospitals & clinics is expected to be the largest segment of the market due to increase in the number of patients coming in through reimbursement programs such as Medicare.

North America to Lead C-arms Market

North America held major share of the global C-arms market in terms of revenue in 2018 and the trend is projected to continue during the forecast period. High cost of surgical imaging arms in the U.S. and increase in adoption of new and advanced C-arms for integrated and hybrid operating rooms in the country are attributed to North America’s large share of the global C-arms market in 2018. The C-arms market in Asia Pacific is anticipated to expand at a relatively high CAGR of 4% during the forecast period owing to rise in focus on the development of healthcare infrastructure by public as well as private hospitals and increase in demand for affordable care among a significant base of patient population.

Pre Book C-arms Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=74778<ype=S

Leading Players in Global Market

The report provides profiles of leading players operating in the global C-arms market. These include ATON GmbH (Ziehm Imaging, Inc. and OrthoScan, Inc.), Canon Medical Systems Corporation, Eurocolumbus s.r.l., Shimadzu Corporation, Koninklijke Philips N.V., Siemens Healthineers AG, GE Healthcare, Hologic, Inc., and DMS Imaging. GE Healthcare specializes in performance improvement solutions, biopharmaceutical manufacturing technologies, drug discovery, patient monitoring & diagnostics, digital solutions, and medical imaging. Its products and services are sold across the world, primarily to the life sciences research sector, biotechnology & pharmaceutical companies, and medical facilities.

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum, from healthy living and prevention to diagnosis, treatment, and home care. It offers a broad portfolio of C-arms for orthopedic, vascular, and cardiovascular procedures.

More Trending Reports by Transparency Market Research –

Thrombectomy Devices Market:

https://www.biospace.com/article/thrombectomy-devices-market-growing-preference-for-minimally-invasive-surgeries-to-fuel-demand-for-thrombectomy-devices/

Read our Case study at

https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

HIV Self-test Kits Market Demand and Competitive Analysis by Leading Manufacturers

6 min read

HIV Self-test Kits Market: Introduction

According to the report, the global HIV self-test kits market was valued at US$ 60.3 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. HIV self-testing is a screening test, which detects the presence of HIV-1/2 antibodies. HIV self-testing is a test in which a person collects his/her own specimen and performs an HIV test in a private setting. HIV self-test kits are a modified version of HIV rapid diagnostic test (RDT) with comparable sensitivity and specificity. Growing uptake of HIV self-testing policies and implementation is driving HIV self-test kits market globally. Increase in prevalence of HIV infection and strong HIV self-testing product pipeline are major factors anticipated to drive the global HIV self-test kits market during the forecast period.

North America held major share of the global HIV self-test kits market in 2018, owing to the presence of large population suffering from HIV infection, scale-up of new HIV self-testing distribution channels such as workplace programs, and medical insurance schemes in the U.S. The HIV self-test kits market in Asia Pacific is expected to expand at a high CAGR of 18.7% from 2019 to 2027, due to increased donor investment and price reductions in the public sector in low and middle income countries. This, in turn, is likely to drive the demand for HIV self-test kits in emerging markets such as India and China.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75743

Rise in Prevalence of HIV infection Worldwide to Drive HIV Self-test Kits Market

Rise in prevalence of HIV infection globally is projected to drive the HIV self-test kits market during the forecast period. Approximately 37.9 million people were living with HIV in 2018 with 1.7 million people becoming newly infected in 2018 globally. Hence, rise in prevalence and increase in burden of HIV has increased the patient pool undergoing HIV self-testing globally, resulting in high demand for HIV self-test kits, which, in turn, is likely to accelerate the growth of the global HIV self-test kits market in the next few years.

Lateral Flow Immunoassay to Dominate HIV Self-test Kits Market

In terms of technology, the global HIV self-test kits market can be classified into immunofiltration, lateral flow immunoassay, and fluorescent chromatography. The lateral flow immunoassay segment dominated the global HIV self-test kits market in 2018 and the trend is projected to continue during the forecast period, as lateral flow immunoassay is a gold standard for HIV self-testing and most common technology used in HIV self-test kits.

Blood to be Key Specimen Type in HIV Self-test Kits Market

In terms of specimen type, the global HIV self-test kits market has been segmented into blood, oral fluid, and urine. The blood segment accounted for majority of the HIV self-test kits market share in 2018. Various blood-based HIV self-testing products are under development, which would be featured with painless or integrated lancets, simplified sampling systems, and integrated buffer delivery systems. Furthermore, these products are likely to have shorter minimum and maximum reading time, which is expected to propel the blood segment during the forecast period. Growth of the urine and oral fluid segments can be attributed to simplicity of procedures for collecting samples than taking blood. Studies have also reported that HIV self?testing with oral fluid self?test kits is accurate, with sensitivity of at least 91.7% and specificity of at least 97.9%.

Request for Analysis on COVID-19 Impact on HIV Self-test Kits Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75743

Increase in Second Generation Tests

In terms of test generation, the global HIV self-test kits market has been categorized into second generation and third generation. The second generation segment held major share of the global HIV self-test kits market in 2018. According to UNITAID, WHO, and PSI, majority of the HIV rapid diagnostic tests for self-testing in the market as well as in development are second generation tests.

North America to Lead HIV Self-test Kits Market

In terms of region, the global HIV self-test kits market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for major share of the global HIV self-test kits market during the forecast period, owing to increase in number of individuals suffering from HIV infection.

According to the U.S. Department of Health & Human Services, approximately 1.1 million individuals are infected with HIV, out of which 15% are unaware about HIV infection, which is anticipated to boost HIV self-test kits usage to check HIV status. This, in turn, is expected to drive the demand for HIV self-test kits for patient care in the country. Favorable funding by the governments and charitable trusts for HIV self-testing, prevention, and treatment in the region is likely to drive the HIV self-test kits market in North America.

The HIV self-test kits market in Asia Pacific is projected to grow at a rapid pace in the next few years. India and China are anticipated to be lucrative markets for HIV self-test kits during the forecast period, because of growing health care sector, rise to demand for use of in vitro diagnostic kits, and high incidence of HIV infection.

Buy HIV Self-test Kits Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=75743<ype=S

Growth Strategies of Key Players

Key players operating in the global HIV self-test kits market include OraSure Technologies, Inc., Chembio Diagnostic Systems, Atomo Diagnostics, BioSure UK, Biosynex Group, bioLytical Laboratories Inc., Orange Life, Bedfordbiotech, and Sedia Biosciences Corporation. These companies engage in developing partnerships with in-country distributors and organizations that have experience in local regulatory and approval processes in order to expand product offerings and customer base. For instance, in September 2018, Mylan N.V. and Atomo Diagnostics underwent a strategic partnership to commercialize CE-Marked in vitro HIV rapid diagnostic test for self-testing in low- and middle-income countries.

More Trending Reports by Transparency Market Research –

Corporate Wellness Market:

https://www.biospace.com/article/corporate-wellness-market-need-for-improved-employee-performance-to-propel-demand-tmr/

Read our Case study at

https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

Non-Invasive Prenatal Testing Market: Comprehensive study explores Huge Growth in Future

7 min read

Non-Invasive Prenatal Testing Market: Introduction

Transparency Market Research has published a new report titled ‘Global Non-Invasive Prenatal Testing Market’. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027.

Overview

·        Rise in prevalence of chronic conditions, such as cancer and diabetes, has increased the patient pool, followed by rise in demand for biologic drugs for treating various chronic conditions, resulting in boosting the growth of the Non-Invasive Prenatal Testing market

·        The market is anticipated to witness strong growth from 2019 to 2027. Increasing demand for early and non-invasive procedures is also considered as a major factor driving the NIPT market globally. For pregnant women at high risk of fetal chromosomal abnormalities (women aged 35 years and older, personal or family history of aneuploidy and positive result with conventional screening method), making a decision at early stage is very important, as a delay may lead to unnecessary pain and discomfort along with developmental issues with the fetus.

Request a PDF Brochure -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=374

·        Rising demand for early screening is projected to trigger the demand for NIPTs globally, as most NIPTs available in the market can be recommended as early as 9 weeks to 10 weeks of gestation. Traditional invasive prenatal testing, such as amniocentesis and chronic villus sampling (CVS), are associated with the risk of miscarriage. On account of the fact that NIPTs completely eliminate the risk of miscarriage, they are being increasingly preferred by women over invasive prenatal testing.

·        Globally, the average age of first-time mothers is increasing, especially in developed countries such as U.S., U.K., France, Germany, Italy, and Japan. Financial stability, rising literacy rates, and social factors are key factors responsible for the advancing maternal age. The risk of fetal chromosomal aneuploidies is directly related to the rise in maternal age.

·        Increasing maternal age and advantages of NIPT over traditional invasive testing are some of the factors responsible for driving the market growth

Materni21 Test Type Segment to Dominate Global Market

·        Based on test type, the MaterniT21 segment accounted for major share of the global non-invasive prenatal testing market in 2018.

·        Dominance of the segment in the global market is attributable to strong brand reputation of MaterniT21 and acquisition of Sequenom by Labcorp.

·        In the U.S, Sequenom (which is presently a part of Labcorp) introduced MateriT21 in 2011, which was the first NIPT solution in the U.S. MaterniT21 is able to identify trisomies and expanded tests may also explain sex chromosomes disabilities and some microdeletions. Less percentage error is a significant advantage of MaterniT21. In addition to MaterniT21, the panorama segment held a notable share of the market, in terms of volume, in 2018.

Request for Analysis of COVID19 Impact on Non-Invasive Prenatal Testing Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=374

Trisomy Tests to Witness High Adoption During Forecast Period

·        Based on application, the trisomy segment held a prominent share in 2018 in non-invasive prenatal testing market. The segment is likely to be highly lucrative during the forecast period.

·        According to the United Nations, the estimated rate of incidence of Down Syndrome ranges from 1 in 1,000 live births per year to 1 in 1,100 live births per year. Around 95% cases of Down Syndrome are nondisjunction cases, whereas translocation and mosaicism cases account for the rest of 5%.

·        Dominance of the trisomy segment is attributable to the increasing prevalence of Down Syndrome worldwide and high efficiency of NIPT for screening of Down Syndrome.

Global Non-Invasive Prenatal Testing Market: Prominent Regions

·        North America held the largest share of the global Non-Invasive Prenatal Testing market in 2018. North America accounted for significant share of the global Non-Invasive Prenatal Testing market in 2018. The market in the region is likely to grow at a rapid pace during the forecast period.

·        The market in the region is driven by presence of key players, large number of research activities, and highly structured health care industry

·        Increase in investment by key players in North America and increasing maternal age are projected to propel the non-invasive prenatal testing market in North America

·        The U.S. is projected to dominate the non-invasive prenatal testing market in the region during the forecast period, owing to early adoption of technologies. The country is anticipated to be the most attractive market for non-invasive prenatal testing, with high attractiveness index.

·        Well-equipped hospitals, technological advancements, rise in research & development in non-invasive prenatal testing for new applications, and surge in demand for novel products and treatments are projected to ameliorate the non-invasive prenatal testing market in the U.S.

Buy Non-Invasive Prenatal Testing Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=374<ype=S

Global Non-Invasive Prenatal Testing Market: Key Players

·        Players are strengthening their product portfolio and are collaborating with other companies to secure and strengthen their positions in the non-invasive prenatal testing market. For instance, in July 2018, Berry Genetics partnered with 10X Genomics to upgrade non-invasive DNA prenatal testing. This collaboration was the first step for 10X Genomics to enter into the market in China.

·        In July 2016, Laboratory Corporation announced the acquisition of Sequenom for US$ 371 Mn, including debt. With this acquisition, Laboratory Corporation would strengthen its presence outside the U.S., in Europe and Asia Pacific, and enable it to provide top quality NIPT services.

·        Major players operating in the global Non-Invasive Prenatal Testing market include Berry Genetics, BGI, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Illumina, Inc, F. Hoffmann-La Roche Ltd, NATERA, INC., PerkinElmer Inc, Eurofins LifeCodexx AG, and IGENOMIX.

More Trending Reports by Transparency Market Research –

Diagnostic Imaging Services Market:

http://www.prnewswire.com/news-releases/increasing-adoption-of-new-technology-to-help-diagnostic-imaging-services-market-reach-valuation-worth-us465-bn-by-2027-transparency-market-research-301008184.html

Respiratory Inhaler Market:

https://www.biospace.com/article/respiratory-inhaler-market-approvals-of-various-respiratory-inhaler-products-in-recent-time-is-expected-to-flourish-the-market/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

Medical Device Cleaning Market: Study Navigating the Future Growth Outlook

6 min read

Medical Device Cleaning Market: Introduction

According to the report, the medical device cleaning market was valued at ~US$ 2.8 Bn in 2018 and is expected to expand at a CAGR of ~5% during the forecast period. It is projected to expand at a rapid pace during the forecast period. Medical device cleaning is an essential and integral part of any surgical procedure. Most medical devices such as scalpels, scissors, retractors, forceps, and endoscopes, are reused in healthcare set ups. These need to be cleaned and sterilized properly prior to their use in subsequent surgical procedures in order to prevent any kind of infections and cross contamination among patients as well as healthcare workers.

The medical device cleaning process comprises pre-cleaning, cleaning, disinfection, and sterilization. In the whole process of medical device cleaning, different types of chemicals and detergents are utilized at each stage of the cleaning process. The type of chemicals and detergents used for medical device cleaning varies according to the type of medical device to be cleaned. Enzymatic and non-enzymatic detergents, glutaraldehyde, peracetic acid, and alcohol are widely utilized medical device cleaners across the globe.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30965

Increase in Use of Chemicals to Drive Global Market

In terms of product, the medical device cleaning market has been classified into detergents and chemicals. The chemicals segment has been further sub-segmented into aldehydes, hydrogen peroxide, alcohol, chlorine based disinfectants, peracetic acid, quaternary ammonium compounds, and others. Chemicals is anticipated to be the leading segment of the global medical device cleaning market during the forecast period. Aldehydes are extensively used for a broad spectrum of activities, as disinfectants and antiseptics against bacteria and their spores, fungi, and viruses. The extensive usage of aldehyde for disinfecting wide range of surgical instruments is expected to propel the segment during the forecast period.

Various Advantages of Automatic Cleaning Process to Fuel Demand

In terms of process, the medical device cleaning market has been segregated into manual cleaning and automatic cleaning. The automatic cleaning segment is projected to be lucrative segment during the forecast period. The segment is projected to expand at a rapid pace during the forecast period and is likely to gain market share by the end of 2027.

Advantages offered by automatic cleaning, such as optimum levels of medical device cleaning, reduced turnaround time, personnel safety and high levels of sterility, is a key factor contributing to the dominant share held by the automatic cleaning segment of the global market.

Request for Analysis of COVID-19 Impact on Medical Device Cleaning Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30965

Surgical Instruments a Key Application Area

In terms of application, the global medical device cleaning market has been segregated into surgical instruments, ultrasound probes, endoscopes, and others. The surgical instruments segment held a significant share of the market in 2018. This trend is anticipated to continue during the forecast period. Majority of the handheld instruments, such as scalpels, forceps, retractors, and scissors, are an integral part of any surgical procedure. These instruments need to be cleaned and sterilized prior to next surgical procedures. Large volume and high frequency of cleaning of surgical instruments in hospitals and ambulatory surgical centers have contributed to dominant share held by the segment of the global market.

The endoscopes segment is projected expand at a notable CAGR during the forecast period, owing to rapid increase in number of minimally invasive surgeries in developed countries such as Japan, Germany, France, the U.K., and the U.S. Moreover, a rise in the demand for endoscopic procedures in emerging economies across the globe is a key factor that is estimated to boost the endoscopes segment of the market during the forecast period.

Medical Device Cleaning Market: Prominent Regions

The global medical device cleaning market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global medical device cleaning market in 2018, followed by Europe. This can be attributed to new product development, early adoption of technological advanced products, and presence of key players in the region. The market in Asia Pacific is projected to expand at a prominent CAGR during the forecast period, owing to a large number of patients with chronic burn injuries and cancer in India, China, Australia, and New Zealand; rise in per capita health care expenditure; and increase in access to health care in the region.

The market in Latin America and Middle East & Africa is anticipated to expand at a moderate pace owing to increase in investments in healthcare infrastructure by private as well as governments organizations, increase in awareness about hospital acquired infections, and surge in number of surgical procedures in these regions

Buy Medical Device Cleaning Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=30965<ype=S

Launch of Innovative Products and M&A by Key Players to Augment Global Market

The medical device cleaning market is highly fragmented, with a large number of players holding majority share in domestic market. Development and commercialization of automatic medical device cleaning is a key trend witnessed among leading players of the global medical device cleaning market. Moreover, the companies engage in mergers and acquisitions to broaden their product offerings in medical device cleaning and consolidate their position in the global market.Prominent players operating in the global medical device cleaning market include 3M Company, Getinge AB, Cantel Medical Corp., STERIS plc., Fortive Corporation, Oro Clean Chemie AG, Ruhof Corporation, Ecolab Inc, and Dr. Weigert.

More Trending Reports by Transparency Market Research –

Veterinary Radiography System Market:

http://www.prnewswire.com/news-releases/animal-health-gains-prominence-as-role-shifts-from-pets-to-companions-contributing-to-growth-in-veterinary-radiography-system-market-notes-tmr-301022155.html

Read our Case study at

https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

Optic Nerve Disorders Treatment Market: Growing Demand and Growth Opportunity

6 min read

Optic Nerve Disorders Treatment Market: Introduction

According to the report, the optic nerve disorders treatment market was valued at approximately ~US$ 14.1 Bn in 2018. It is expected to expand at a CAGR of ~4% during the forecast period from 2019 to 2027. Optic nerve disorders treatment comprise medications and surgery, which treat optic nerve disorders (glaucoma, optic neuritis, and other related disorders). The optic nerve is a bundle of more than 1 million nerve fibers that carry visual messages. Damage to an optic nerve can cause vision loss depending on severity of damage to the optic nerve. Optic nerve disorders are a group of disorders related to optic nerves caused due to damage to optic nerves, which can lead to vision loss or eventually complete blindness.

Growth of the optic nerve disorders treatment market can be ascribed to increase in prevalence of optic nerve disorders and other related eye disorders across the globe. North America dominated the optic nerve disorders treatment market in 2018 and is projected to continue its dominance during the forecast period, owing to the rise in the number of prescriptions for glaucoma treatment in the region and high prevalence of optic nerve disorders.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=68075

Rise in Prevalence of Eye Disorders in Geriatric Population to Drive Optic Nerve Disorders Treatment Market

Growing prevalence of different eye disorders, which are rising due to optic nerve damage is a major factor responsible for the growth of the optic nerve disorders treatment market. Rise in aging population, which is more prone to ophthalmic problems, such as low sight vision is also a prime factor responsible for the expansion of the optic nerve disorders treatment market. According to National Institutes of Health, population aged 65 and above in the U.S. is projected to nearly double in the next three decades, from 48 million to 88 million by 2050. Moreover, high adoption rate of digital devices is also fueling the expansion of the optic nerve disorders treatment market due to adverse impact on vision.

High Demand for Pharmacological Treatment

In terms of treatment type, the optic nerve disorders treatment market has been bifurcated into pharmacological treatment and surgery. Pharmacological treatment dominated the optic nerve disorders treatment market in 2018. This segment is expected to dominate during the forecast period due to low cost and better efficacy of different medications. The pharmacological treatment segment has been further divided into prostaglandins, beta interferons, beta blockers, alpha-adrenergic agonist, carbonic anhydrase inhibitors, corticosteroids, combination drugs, and others.

Prostaglandins accounted for a major share of the pharmacological treatment segment. Rise in demand for prostaglandins as a first line treatment option in glaucoma and increase in the number of prescriptions of this class are some of the major factors impacting the prostaglandins segment.

Request for Analysis of COVID-19 Impact on Optic Nerve Disorders Treatment Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=68075

Glaucoma to be a Major Indication

In terms of indication, the optic nerve disorders treatment market has been segmented into glaucoma, optic neuritis, optic neuropathy, and others. Glaucoma segment dominated the global market and is likely to expand at a high CAGR during the forecast period, owing to rise in prevalence of glaucoma and launch of effective combination products for glaucoma.

Rise in Number of Hospital Admissions for Ophthalmologic Problems

Based on end user, the optic nerve disorders treatment market has been divided into hospitals, ambulatory surgery centers, clinics, and others. Hospitals segment is expected to account for major share during the forecast period. Increase in the number of hospital admissions and ability of hospitals to provide optimum health care services to patients are some of the major driving forces for the expansion of the hospitals segment.

Clinics segment is also projected to be a lucrative segment during the forecast period, owing to the increase in the number of ophthalmic clinics in developed as well as developing regions and inclination of patients to avail treatment in specialized clinics for treatment of diseases.

Buy Optic Nerve Disorders Treatment Market Report at

https://www.transparencymarketresearch.com/checkout.php?rep_id=68075<ype=S

North America to Dominate Global Market

In terms of region, the optic nerve disorders treatment market has been divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the optic nerve disorders treatment market in 2018 and is projected to remain dominant during the forecast period.

High prevalence of optic nerve disorders and a favorable reimbursement scenario for surgeries are some of the factors responsible for the dominance of North America in the optic nerve disorders treatment market. Asia Pacific is a more lucrative market for optic nerve disorders treatment. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period, due to increase in geriatric population, rise in prevalence of glaucoma, and availability of generic drugs.

Competition Landscape

The optic nerve disorders treatment market is fragmented in terms of number of players. Key players in the global market include Santen Pharmaceutical Co., Ltd., Allergan plc. Novartis AG, Pfizer, Inc., Bausch Health Companies, Inc., Aerie Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Bionure Farma, S.L., and Mallinckrodt Pharmaceuticals. Novartis AG, Allergan plc., and Santen Pharmaceutical Co., Ltd.  are some of the leading players in the global market. New product launches, higher R&D investment, and strategic partnership for mergers, acquisitions, distribution, and a widespread distribution channel are some of the key strategies adopted by major players operating in this market.

More Trending Reports by Transparency Market Research –

Pressure Relief Devices Market:

https://www.prnewswire.com/news-releases/shining-growth-prospects-in-pipeline-for-pressure-relief-devices-market-on-back-of-surging-demand-for-foam-based-mattresses-says-tmr-301113102.html

Cleanroom Consumables Market:

https://www.biospace.com/article/cleanroom-consumables-witnessing-rising-demand-due-to-its-importance-in-healthcare-industry-tmr/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

Biosimilars Market to See Booming Growth

6 min read

Biosimilars Market: Introduction

Biosimilars can be defined as a biologic medical product, which is considered to be similar to already approved biologic. These biosimilars are approved based on their efficacy, quality, safety, and the same standards of pharmaceutical quality that apply to all biologic medicines. Chronic disease prevalence has been increasing significantly at the global level. This necessitates the need for affordable treatment, contributing to the growth of the biosimilars market.

Europe dominated the biosimilars market in 2018 and the trend is anticipated to continue during the forecast period. The strong growth of the market in the region can be attributed to increase in approvals of biosimilars in Europe. For instance, in 2018, over 16 biosimilars were approved in the region for various indications, including oncology, chronic diseases, and autoimmune diseases.

Patent Expiry of Major Biologics to Accelerate Market Growth

Patent expiries of major biologics are expected to contribute to the growth of the biosimilars market.

For instance, the U.S. patent of MabThera/Rituxan (rituximab), a biologic manufactured by Roche, expired in 2016. This provides ample growth opportunities to manufacturers of rituximab biosimilar, such as Amgen, Boehringer Ingelheim, and Pfizer. In addition, a range of top selling brands including Herceptin, Enbrel, Humalog, and Aranesp are anticipated to lose patents during the forecast period.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=118

Increase in Approvals of Biosimilars to Drive Global Market

The U.S. has witnessed a wave of biosimilar approvals in 2019. According to the Antibody Society in the U.S., over 16 antibody biosimilar therapeutics were approved  from 2015 to 2019. Drugs approved in 2019 include Trazimera, Kanjinti, and Ruxience.

As per the FDA’s Biosimilars Action Plan, new policies are being made to make the development of biosimilars more efficient and provide significant opportunities to biosimilar manufacturers. This is anticipated to propel the rate of biosimilar approvals in the U.S., contributing to the growth of the biosimilars market.

High Demand for Recombinant Non-glycosylated Protein Biosimilars

In terms of product, the recombinant non-glycosylated proteins segment is likely to account for a major share of the global biosimilars market. Moreover, the insulin sub-segment of the recombinant non-glycosylated proteins segment dominated the market in 2018. It is likely to grow at a high CAGR during the forecast period, due to increase in prevalence of diabetes globally. According to the International Diabetes Federation, over 463 million adults aged between 20 years and 79 years lived with diabetes in 2019.

Request for Analysis of COVID-19 Impact on Biosimilars Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=118

Biosimilars for Oncology Indication to Dominate Global Market

In terms of indication, the global biosimilars market has been divided into chronic diseases, oncology, autoimmune diseases, infectious diseases, blood disorders, growth hormone deficiency, and others. The oncology segment held the largest market share in 2018 and the trend is anticipated to continue during the forecast period. The robust growth of the segment can be attributed to rise in prevalence of cancer cases globally. According to the World Cancer Research fund, over 18 million cancer cases were reported in 2018. In addition, the patent expiration of a range of cancer biologic drugs, leading to the growing usage of biosimilars, owing to their lower costs contributes to the growth of the segment in the forecast period.

Biosimilars Market: Prominent Regions

In terms of region, the global biosimilars market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominated the global biosimilars market in 2018. This can be attributed to the significant price reduction in biosimilars as compared to biologics, and country policies in Europe enabling the penetration of biosimilars to enhance patient access to affordable treatment, contributes to the growth of the market in Europe. 

The biosimilars market in Asia Pacific is likely to expand at a rapid CAGR from 2019 to 2027. Increase in population of Asian countries, rise in urbanization, surge in aging population, lifestyle changes, and growing incidence of non-communicable diseases such as diabetes, cancer, and autoimmune diseases are driving the biosimilars market in Asia Pacific. Furthermore, various countries in South Asia have been assigning a major portion of their medical research budget for the development of biosimilars.

Buy Biosimilars Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=118<ype=S

Biosimilars Market: Key Strategies

The global biosimilars market is consolidated in terms of number of players. Key players operating in the global biosimilars market include Pfizer, Inc., Intas Pharmaceuticals Ltd., Biocon, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (A Novartis Division), Celltrion Inc., Amgen, Inc., STADA Arzneimittel AG, and Apotex Inc. (Apobiologix).

These players have adopted various strategies such as product portfolio expansion, investment in research & development, collaborations, and product launches to establish a strong geographic presence. For instance, in November 2019, Pfizer received the U.S. FDA approval for its ABRILADA, a biosimilar to Humira, for the treatment of patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

More Trending Reports by Transparency Market Research –

Membrane Filters Market:

https://www.biospace.com/article/membrane-filters-market-polyethersulfone-pes-membranes-segment-to-drive-membrane-filters-market/

Read our Case study at

https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Pooja Mahajan

Veterinary Orthopedic Implant Market Size and Forecast | Industry overview, Latest Trend and Growth Analysis

5 min read

Transparency Market Research (TMR) has published a new report titled ‘Veterinary Orthopedic Implant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global veterinary orthopedic implant market was valued at US$ 86.3 Mn in 2017. It is projected to expand at a CAGR of 7.1% during forecast period from 2018 to 2026. The global market is anticipated to be driven by an increase in companion animal population, rise in pet adoption, and increase in R&D expenditure on animal health. The veterinary orthopedic implant market in North America is expected to expand at a high CAGR of 7.6%, due to an increase in the livestock population and rise in awareness about pet ownership in countries such as the U.S. and Canada.

Increase in Companion Animal Population Drives Market

The number of companion animals, including domestic pets, horses, and service animals, is increasing rapidly across the globe. According to the American Pet Products Association (APPA), households in the U.S. owned around 94.2 million cats in 2017 compared to 70 million in 2000. Similarly, the dog population increased by 21.7 million between 2000 and 2017 to reach 89.7 million. Based on the Animal Health Europe Survey (2017), Europe witnessed a 9% increase in pet population between 2012 and 2016. Rise in pet adoption fuels the growth of the veterinary orthopedic implant market. For instance, the pet ownership in the U.S. has displayed an upward trend in the last two decades. Currently, 68% of all households, i.e., 84.6 million homes, in the U.S. own a pet compared to 56% in 1988. Hence, pet ownership has increased by 12% in the U.S. since 1988. Increase in the number of pet owners is expected to drive demand for veterinary care services, which is likely to boost market growth in the next few years.

Request Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53937

Veterinary Plates & Screws Segment Dominated the Market

In terms of product type, the global veterinary orthopedic implant market has been classified into veterinary plates & screws, joint replacement implants, and others. Joint replacement implants are further classified into hip replacement implants, knee replacement implants, and others. The veterinary plates & screws segment is projected to account for a leading share of the global market during the forecast period, owing to the wide usage of veterinary plates & screws, especially in sport injuries and accidents. The joint replacement implant segment includes hip & knee replacement implants. The segment is expected to expand at a robust CAGR in the next few years, due to a rise in the prevalence of bone and joint diseases in animals.

Veterinary Hospitals & Clinics to be a Highly Promising Segment

In terms of end-user, the global veterinary orthopedic implant market has been segmented into veterinary hospitals & clinics and research institutes. The veterinary hospitals & clinics segment held a major share of the global market in 2017. Expansion of the segment can be attributed to the availability of multiple service options and devices and tie-ups with health care companies in order to enhance health care product and service offerings.

Request for Analysis of COVID-19 Impact on Veterinary Orthopedic Implant Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=53937

Market in North America to Expand at a Strong Growth Rate and Create High Incremental Opportunity

In terms of region, the global veterinary orthopedic implant market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for a leading share of the global market during the forecast period, owing to high adoption of companion animals, increase in pet expenditure, and presence of a large number of veterinary hospitals & clinics in the region. Europe is anticipated to account for a significant share of the global market between 2018 and 2026.

Increase in the number of veterinarians and rise in R&D expenditure on animal health are expected to fuel the growth of the market in the region during the forecast period. The market in Asia Pacific is likely to expand at an average pace in the next few years. This is attributed to an increase in livestock population and rise in the number of companion animals in countries such as Australia and Japan. Australia has 63% pet ownership, which is one of the highest rates in the world. The veterinary orthopedic implant market in Latin America and Middle East & Africa is anticipated to expand at a steady pace from 2018 to 2026.

Buy Veterinary Orthopedic Implant Market Report at

https://www.transparencymarketresearch.com/checkout.php?rep_id=53937<ype=S

Growth Strategies by Key Market Players

Key players profiled in this report are B. Braun Melsungen AG, Johnson & Johnson, Veterinary Orthopedic Implants, Inc., BioMedtrix, LLC, KYON Veterinary Surgical Products, IMEX Veterinary, Inc., Orthomed (UK) Ltd, and Securos Surgical. Companies operating in the global veterinary orthopedic implant market focus on strategic collaborations, acquisitions, and partnership strategies to expand product offering and strengthen market foothold.

More Trending Reports by Transparency Market Research –

Behavioral Health Market:

https://www.prnewswire.com/news-releases/as-stress-and-anxiety-impacts-an-increasing-number-of-people-behavioral-health-market-is-pushed-on-higher-growth-trajectory-tmr-study-301106761.html

Population Health Management Market:

https://www.biospace.com/article/population-health-management-market-mergers-and-acquisitions-are-key-strategies-for-leading-companies-in-industry-tmr/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/